MLM Medical Labs News and Insights
03 December 2025
Key Flow Cytometry Markers Assessed Across Multiple Disease Categories
Flow cytometry is an invaluable...
Read More
04 November 2025
MLM Medical Labs leads in IVDR LDT Alzheimer’s biomarker testing with a validated Lumipulse® pTau217/Beta-Amyloid...
Read More
08 October 2025
Sponsors of global clinical trials don’t need another oversized, bureaucratic lab — they need a right-sized,...
Read More
02 October 2025
Infectious disease trials demand speed, precision, and regional expertise. This article explores the...
Read More
12 September 2025
A mid-sized biopharmaceutical company planning a global Phase II immuno-oncology trial in advanced solid...
Read More
24 August 2025
A mid-sized biopharmaceutical company planning a global Phase II immuno-oncology trial in advanced solid...
Read More
31 July 2025
A mid-sized biopharmaceutical company planning a global Phase II immuno-oncology trial in advanced solid...
Read More
03 June 2025
MLM Medical Labs (MLM), a global leader in central and specialty laboratory services, is pleased to announce...
Read More
31 May 2025
A mid-sized biopharmaceutical company planning a global Phase II immuno-oncology trial in advanced solid...
Read More
22 May 2025
MLM Medical Labs Approved by French Ministry for R&D and Innovation Tax Incentives
Decision strengthens...
Read More
December 3, 2025
Key Flow Cytometry Markers Assessed Across Multiple Disease Categories
Flow cytometry is an invaluable...
November 4, 2025
MLM Medical Labs leads in IVDR LDT Alzheimer’s biomarker testing with a validated Lumipulse® pTau217/Beta-Amyloid...
October 8, 2025
Sponsors of global clinical trials don’t need another oversized, bureaucratic lab — they need a right-sized,...
October 2, 2025
Infectious disease trials demand speed, precision, and regional expertise. This article explores the...
September 12, 2025
A mid-sized biopharmaceutical company planning a global Phase II immuno-oncology trial in advanced solid...
August 24, 2025
A mid-sized biopharmaceutical company planning a global Phase II immuno-oncology trial in advanced solid...
July 31, 2025
A mid-sized biopharmaceutical company planning a global Phase II immuno-oncology trial in advanced solid...
June 3, 2025
MLM Medical Labs (MLM), a global leader in central and specialty laboratory services, is pleased to announce...
May 31, 2025
A mid-sized biopharmaceutical company planning a global Phase II immuno-oncology trial in advanced solid...
May 22, 2025
MLM Medical Labs Approved by French Ministry for R&D and Innovation Tax Incentives
Decision strengthens...
No posts found
